Tobira Therapeutics, Inc. (TBRA) - NASDAQ
  • Bhavneesh Sharma | Send Message 18 May

    Buy Tobira Therapeutics For Its NASH Drug Candidate $TBRA
      • EP Vantage | Send Message 13 May

        NASH Data From Tobira And Karyopharm's Myeloma Trial $TBRA
          • Bay Area Biotech | Send Message 5 Jan

            Tobira Therapeutics: A Key Player In The NASH Landscape $TBRA
              • Biotech Connection | Send Message 17 Dec 2015

                Tobira Therapeutics: A Worthy Contender In The NASH Space $TBRA
                  • Indianaman777 | Send Message 9 Jun 2015

                    why does SA say this company $TBRA is defunct because of a merger? Someone has wires or them??
                      • Newbigtech | Send Message 22 May 2015

                        Bought More $ARIA today.. Also Buying $PMCB and $TBRA.
                        Reply (2)
                        • matratra | Send Message 22 May 2015
                          : I do like ARIA & it may be acquired.
                        • Tile | Send Message 22 May 2015
                          : $pmcb. Good choice.
                          • Tom Landry | Send Message 28 Apr 2015

                            Quiet morning, do I read that right? $LCI, $INCY, $TBRA, $HZNP, $VRX, $TNXP.
                              • Daniel Ward | Send Message 20 Jan 2015

                                Biotech Weekly: The Failed Biotech Life Cycle And The Regado-Tobira Merger $TBRA
                                  • Daniel Ward | Send Message 15 Jan 2015

                                    Regado Biosciences Long Thesis Remains Intact $TBRA
                                      • Bajorek | Send Message 14 Jan 2015

                                        $TBRA merger announced with Tobira Therapeutics, Inc.. $RGDO shareholders will own 32% of new company. Shares to skyrocket today!!
                                        Reply (1)
                                        • cameron0208 | Send Message 14 Jan 2015
                                          : Up $0.34 in PM. Think it will keep going?
                                          Company Description
                                          Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, infalmmation, fibrosis, and human immunodeficiency virus (HIV). Its lead product candidate, cenicriviroc or CVC, is a proprietary... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States